We investigated the e¡ect of novel phytosphingosine derivatives, N-acetyl phytosphingosine (NAPS) and tetraacetyl phytosphingosine (TAPS), on induction of apoptosis in HaCaT cells in comparison with C 2 -ceramide. NAPS/TAPS e¡ectively decreased cell viability in a dose dependent manner mainly due to apoptosis. An apoptosis expression array analysis showed that in the TAPS treated cells 13 genes including COX-2 encoding cyclooxygenase-2, the most induced by TAPS, were upregulated while 23 others down-regulated. Therefore, we examined the mechanism underlying the altered expression of COX-2. Assays with inhibitors and antibodies against proteins involved in signal transduction demonstrated that NAPS and TAPS elevated COX-2 expression via tyrosine kinase, src, PI-3 kinase and PKC, followed by ERK activation. However, P38 was not involved in the NAPS-mediated COX-2 expression but in the TAPS-mediated. We further demonstrated by FACS analyses that NAPS-or TAPS-mediated apoptosis was greatly increased in cells treated with celecoxib, a selective COX-2 inhibitor. Inhibition of the ERK pathway apparently involved in the NAPS/TAPS-mediated COX-2 expression enhanced the NAPS/TAPS-mediated apoptosis, whereas inhibition of the P38 pathway did not. These results suggest that expression of COX-2 in the TAPS-or NAPS-treated cells may be increased to counteract the e¡ect of those compounds on apoptosis. . Sphingolipid metabolites such as ceramides and sphingosines play important parts in regulating cellular activities, and have been implicated as putative second messengers in the signaling pathways (Merrill et al, 1997) . Ceramides regulate cell di¡erentiation, cell cycle arrest, proliferation, and apoptosis (Mathias et al, 1998; Perry and Hannun, 1998) . Sphingosine also induces apoptosis and growth inhibition in various cell types as an intracellular signal mediator (Spiegel and Merrill, 1996) . Phytosphingosine (PS) is abundant in fungi and plants (Dickson, 1998 ) and is present in animals, including humans (Schurer et al, 1991) . PS is structurally similar to sphingosine and ceramide with one major di¡erence: PS possesses a hydroxyl group at C-4 of the sphingoid long-chain base, whereas sphingosine and ceramide both contain a trans double bond between C-4 and C-5 Cyclooxygenase (COX)-2 overexpression in cancer cells may promote tumor growth by imparting resistance to apoptosis. Consistent with this, a null COX-2 mutation in APC D716 knockout mice, which is a murine model of familial adenomatous polyposis, restored the apoptosis and reduced the size and the number of colorectal adenomas (Oshima et al, 1996) . The role of COX-2, however, in the induction of apoptosis and in skin tumor development is still controversial. Overexpression of the COX-2 protein has been reported to induce cell cycle arrest independently of the prostaglandins, which leads to the induction of apoptosis (Trifan et al, 1999) . In addition, a speci¢c COX-2 inhibitor, celecoxib induced apoptosis but its proapoptotic e¡ect was independent of COX-2 inhibition in mouse embryo ¢broblasts, which were derived from COX-2( þ /^) and COX-2(^/^) mice (Williams et al, 2000) . Moreover, observations relating to the proapoptotic e¡ect of nonsteroidal anti-in£ammatory drugs has resulted in contradictory conclusions in that the proapoptotic activity of the COX inhibitors occurs via either COX-dependent or COX-independent mechanisms (Rigas and Shi¡, 2000) .
S
phingolipids are found in all eukaryotic cells and enriched in the plasma membranes, Golgi membranes, and lysosomes (Merrill et al, 1997; Huwiler et al, 2000) . Sphingolipid metabolites such as ceramides and sphingosines play important parts in regulating cellular activities, and have been implicated as putative second messengers in the signaling pathways (Merrill et al, 1997) . Ceramides regulate cell di¡erentiation, cell cycle arrest, proliferation, and apoptosis (Mathias et al, 1998; Perry and Hannun, 1998) . Sphingosine also induces apoptosis and growth inhibition in various cell types as an intracellular signal mediator (Spiegel and Merrill, 1996) .
Phytosphingosine (PS) is abundant in fungi and plants (Dickson, 1998 ) and is present in animals, including humans (Schurer et al, 1991) . PS is structurally similar to sphingosine and ceramide with one major di¡erence: PS possesses a hydroxyl group at C-4 of the sphingoid long-chain base, whereas sphingosine and ceramide both contain a trans double bond between C-4 and C-5 (Lee et al, 2001) . It has been reported that both PS and N-acetyl phytosphingosine (NAPS) were involved in the heat stress response of Saccharomyces cerevisiae (Jenkins et al, 1997; Wells et al, 1998) , and induced cell death in Chinese hamster cells (Lee et al, 2001) . Little is known, however, about the cellular functions of the PS derivatives.
Cyclooxygenase (COX)-2 overexpression in cancer cells may promote tumor growth by imparting resistance to apoptosis. Consistent with this, a null COX-2 mutation in APC D716 knockout mice, which is a murine model of familial adenomatous polyposis, restored the apoptosis and reduced the size and the number of colorectal adenomas (Oshima et al, 1996) . The role of COX-2, however, in the induction of apoptosis and in skin tumor development is still controversial. Overexpression of the COX-2 protein has been reported to induce cell cycle arrest independently of the prostaglandins, which leads to the induction of apoptosis (Trifan et al, 1999) . In addition, a speci¢c COX-2 inhibitor, celecoxib induced apoptosis but its proapoptotic e¡ect was independent of COX-2 inhibition in mouse embryo ¢broblasts, which were derived from COX-2( þ /^) and COX-2(^/^) mice (Williams et al, 2000) . Moreover, observations relating to the proapoptotic e¡ect of nonsteroidal anti-in£ammatory drugs has resulted in contradictory conclusions in that the proapoptotic activity of the COX inhibitors occurs via either COX-dependent or COX-independent mechanisms (Rigas and Shi¡, 2000) .
It was reported that ceramides induce apoptosis and enhance COX-2 expression. C 2 -ceramide was shown to increase COX-2 expression through a signal transduction pathway mediated by the extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase (MAPK), which belong to the MAPK family in human mammary epithelial cells (Subbaramaiah et al, 1998) . The MAPK family consists of a set of serine threonine protein kinases, which leads to proto-oncogene expression (Cobb, 1999; Thomson et al, 1999; Pages et al, 2000) . The activated MAPK may translocate to the nucleus, where they phosphorylate their target proteins (Coso et al, 1995) . Ceramides mediate their e¡ects by activating phosphoprotein phosphatases (Dobrowsky and Hannun, 1992) and serine/ threonine kinases (Liu et al, 1994 ) that may increase Raf activity (Zhang et al, 1997) , and by inhibiting phospholipase D (GomezMunoz et al, 1994) .
In this study, we examined the e¡ects of the novel PS derivatives, NAPS and tetraacetyl phytosphingosine (TAPS), on the induction of programmed cell death of an immortalized human keratinocytes cell line HaCaT, and identi¢ed the genes of altered expression in the TAPS-treated cells. TAPS remarkably increased COX-2 expression at the mRNA level. The focus of this study was therefore to examine (1) signaling pathways, by which novel PS derivatives, NAPS and TAPS, turn on the expression of COX-2, and (2) the role of COX-2 in NAPS-or TAPS-mediated apoptosis.
MATERIALS AND METHODS

Materials
The PS derivatives, NAPS and TAPS, were provided from Doosan Biotech (Yongin, Korea), and N-acetyl-D-erythrosphingosine (C 2 -ceramide) was from Sigma (St Louis, Missouri). The identity of PS derivatives was con¢rmed by nuclear magnetic resonance spectroscopy and matrix-assisted laser desorption ionization-time of £ight mass spectrometry. The purity of the NAPS or TAPS was greater than 98% by high performance liquid chromatography (Lee et al, 2001) (Fig 1) . NAPS and TAPS in dimethyl sulfoxide were aliquoted in small amounts and stored at^201C until used. An In Situ Cell Death Detection Kit was obtained from Boehringer Mannheim (Mannheim, Germany). The MTT (3 -(4,5-dimethylthiazol-2-yl) 2,5-diphenyl tetrazolium bromide) and all other chemicals were purchased from Sigma. Celecoxib was kindly provided by Pharmacia Biotech Inc. (San Francisco, California) . [a- 32 P] deoxycytidine triphosphate (3000 mCi per mmol) was purchased from Amersham (Piscataway, New Jersey). Dulbecco's modi¢ed Eagle medium and fetal bovine serum were obtained from Gibco BRL (Rockville, Maryland). Anti-COX-2 and anti-b-tubulin were purchased from Santa Cruz Biotechnology (Santa Cruz, California), and anti-p-MEK1/2 and p-p38 antibodies were obtained from Cell Signaling Technology (Beverly, Massachusetts). PP1, U73122, and GF109203X were obtained from Biomol (Plymouth Meeting, Pennsylvania). Genistein was purchased from Alexis (San Diego, California), and SB203580, U0126, and PD98059 acquired from Calbiochem (San Diego, California). All other chemicals, including LY294002, were purchased from Sigma.
Cell culture The immortalized human keratinocyte cell line, HaCaT, was kindly provided by Professor N. Fuseng (German Cancer Research, Germany). Cells were maintained as monolayer cultures in Dulbecco's modi¢ed Eagle medium supplemented with 10% fetal bovine serum, 100 units per mL penicillin, and 100 mg streptomycin per mL at 371C in a humidi¢ed atmosphere containing 5% CO 2 . The cells were then seeded at a density of 1 Â10 6 cells per 100 mm dishes. After 48 h, the cells were washed with serum-free medium, replaced with media without fetal bovine serum for 12 h prior to treatment with PS derivatives.
Assessment of cell viability (MTT assay) The cell viability was determined colorimetrically using the MTT reagent. The MTT assay was performed as previously described (Wilson and Spier, 1987) .
TUNEL (terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end-labeling) assay TUNEL assay of the nucleosomal DNA fragments using a commercially available ''In Situ Cell Death Detection Kit'' (Boehringer Mannheim) was employed according to the manufacturer's protocol. This method was used to ensure the safe discrimination between apoptosis and necrosis.
Treatment of cells with inhibitors Cells were pretreated with 20 mM LY294002 (an inhibitor of phosphatidylinositol (PI3)-kinase), 40 mM PD98059 (a selective ERK inhibitor), 5 mM SB203580 (a p38 inhibitor), 10 mM U0126 (a MEK inhibitor), 10 mM PP1 (a src family speci¢c inhibitor; Klint et al, 1999) , 100 mM genistein (a tyrosine kinase inhibitor), or 5 mM GF109203X (a protein kinase C (PKC) inhibitor; Wolfe et al, 1996) for 1 h in serum-free medium, and then exposed to 30 mM NAPS or TAPS for the indicated time points. For £uorescence-activated cell sorter (FACS) analysis, cells were also pretreated with 10 mM celecoxib (a speci¢c COX-2 inhibitor) for 1 h, before treatment with 30 mM of either NAPS or TAPS.
Immunochemistry analysis Cells were harvested and lyzed with a RIPA bu¡er containing 0.5% sodium dodecyl sulfate, 1% nonidet P40, 1% sodium deoxycholate, 150 mM NaCl, 50 mM Tris^Cl (pH 7.5), and protease inhibitors. The protein concentration of each sample was determined using a BCA protein assay kit (Pierce, Rockford, Illinois). Twenty micrograms of the total protein for COX-2 detection were electrophoresed on 8% polyacrylamide gels and 80 mg for phospho-MAPK detection on 12% polyacrylamide gels. The proteins were transferred on to the nitrocellulose membranes by a semidry electrophoretic transfer process on a Bio-Rad TransBlot SD (Bio-Rad Laboratories, Hercules, CA) apparatus at 15 V for 60^75 min. The nitrocellulose membranes were blocked overnight at 41C in 5% bovine serum albumin. The membranes were incubated with the primary antibodies in TBST containing 5% bovine serum albumin, for 2 h. This was followed by incubation with the secondary antibodies at room temperature for 1 h. Anti-goat IgG for COX-2 or antirabbit IgG for p-MEK1/2 or p-p38 was used as a secondary antibody (1:5000 dilution in TBST containing 1% bovine serum albumin). The signals were detected using ECL (Amersham).
Flow cytometric analysis FACS analysis was performed using a slight modi¢cation of the method described by Telford et al (1994) . Brie£y, the cells were pelleted at 350 g and washed once with 10 mL of ice-cold phosphate-bu¡ered saline. The pellets were resuspended in 70% ethanol, and then kept on ice for 60 min. Cells were then permeabilized in a reagent consisting of 0.5% Triton X-100, 230 mg per mL RNaseA and propidium iodide to 50 mg per mL in phosphate-bu¡ered saline. The samples were kept at 371C for 30 min followed by £ow cytometry analysis (Becton Dickinson FACScan Becton Dickinson, Franklin Lakes, NJ), and the apoptotic populations (sub-G 1 phase) were analyzed by the CellQuest program (BD Bioscience Franklin Lakes, NJ).
Apoptosis microarray assay An aliquot of 2 mg of total RNA was used in the microarray analyses, which were performed according to the Human Apoptosis Expression Array kit manual (R&D, Minneapolis, Minnesota). Total RNA was reverse-transcribed with avian myeloblastosis virus reverse transcriptase using apoptosis-speci¢c primers and labeled with [a 32p ] cytidine triphosphate. Labeled cDNA were puri¢ed using Sephadex G-25 spin column and hybridized with the array overnight at 651C according to the manufacturer (R&D). Reagents included in the array kit were used for all hybridization. Wash solution I (0.5 Â SSPE, 1% (w/v) (sodium dodecyl sulfate) and wash solution II (0.1 ÂSSPE, 1% (w/v) (sodium dodecyl sulfate) were used for washing steps. Membranes were exposed on Fuji RX X-ray ¢lm.
Analysis of the array results Gene expression data were normalized against the housekeeping gene such as b2M, b-actin, cyclophilin A, HLA-A 0201 heavy chain, hypoxanthine^guanine phosphoribosyltransferase, L19, transferrin R, and a-tubulin which were shown at a constant level in all arrays. The Genesight 3.2 program from Biodiscovery (Biodiscovery Inc. Microray Systems, Marina del Ray, CA) was used to analyze the data, and all gene values were normalized against the housekeeping gene.
Data analysis Scanning densitometry was performed using an Image Master VDS (Pharmacia Biotech Inc.). The one-way ANOVA procedure was used to assess the signi¢cant di¡erences among the treatment groups. For each signi¢cant e¡ect of treatment, the Newman^Keuls test was used for signi¢cance set at po0.05 or po0.01. 
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RESULTS
E¡ects of PS derivatives on the cell viability of the human keratinocytes HaCaT in a concentration-dependent manner
The e¡ects of the PS derivatives, NAPS and TAPS, and C 2 -ceramide on the viability of HaCaT cells were examined using the MTT assay. After incubating the HaCaT cells in the presence of 1 to 30 mM of each compound for 24 h, the cell viability was reduced as the concentration increased (Fig 2) . Considering the ED 50 value, NAPS and TAPS induced the death of keratinocyte cells as e¡ective as C 2 -ceramide in cytotoxicity, but they exerted strong cytotoxicity at 30 mM (viability 20%), compared with C 2 -ceramide (viability 40%). It was reported that the hydroxyl group at C4 -of the sphingosine long-chain base is critical for its anti-proliferative activity and the N-acetyl group is also important for cytotoxicity (Lee et al, 2001 ). These results suggest that PS as well as sphingosine and C 2 -ceramide trigger HaCaT cell death.
PS derivatives induce apoptosis in a concentrationdependent manner A TUNEL assay was performed in order to determine if the cytotoxicity of the PS derivatives was related to apoptosis (Fig 3) . The results show that the TUNEL-positive cells were detected in the NAPS-,TAPS-, or C 2 -ceramide-treated cells at 10 mM and 30 mM, respectively. The percentage of TUNEL-positive cells for TAPS, NAPS, or C 2 -ceramide was 29%, 35%, or 17% at 30 mM, respectively, suggesting that TAPS or NAPS induced apoptosis more e¡ectively than C 2 -ceramide.
Altered expression of genes encoding apoptosis-related proteins in TAPS-treated cells To ¢gure out factors responsible for the apoptosis mediated by a PS derivative, TAPS, we performed apoptosis expression array comprising 198 genes involved in apoptosis. Total mRNA was isolated from the TAPS-treated cells and the control cells, respectively. We identi¢ed genes, whose expression altered by at least 2-fold in the TAPS-treated cells compared with the control cells. The genes with altered expression in the TAPS-treated HaCaT cells were classi¢ed based on their cellular function and listed in Tables I and II. Among 198 genes on the array membrane, 13 genes were increased in TAPS-treated cells compared with control cells, whereas 23 genes were repressed (Tables I and II) . Five genes were cell cycle regulator genes: p21, p53, cyclin A2, CDK2, and RdAp48. It is interesting to note that p21 and p53 were di¡erentially expressed and that p21 was induced, whereas p53 was reduced. Apoptosis suppressor survivin and IAP-1 were downregulated by TAPS. Interestingly, apoptosis array analysis showed that expression of COX-2, which is known to be involved in the proliferation blocking apoptosis in cancer cells, dramatically increased (approximately 16.6-fold) with TAPS (30 mM) treatment.
NAPS and TAPS induce COX-2 protein more than C 2 -ceramide In this study, our focus was to examine the induction mechanism of COX-2 protein by the PS derivatives, NAPS and TAPS, and compared them with PS and C 2 -ceramide. The human keratinocyte cell line, HaCaT, was treated with 30 mM of PS, NAPS, TAPS, or C 2 -ceramide for 24 h. HaCaT cells were incubated with NAPS, TAPS, and C 2 -ceramide at a concentration of 10 and 30 mM for 24 h. The induction of apoptosis by NAPS, TAPS, and C 2 -ceramide was determined by a TUNEL assay as described in Materials and Methods. The experiments were performed three times. Western blot analysis showed that the COX-2 protein level was signi¢cantly higher in the NAPS-or TAPS-treated cells (approximately 15-and 22-fold, respectively) than in the control cells (Fig 4A) . In contrast, the C 2 -ceramide-and PS-treated cells showed a relatively small increase in the COX-2 protein level compared with the control cells. The induction of COX-2 protein was not apparent at a concentration of between 1 and 10 mM, but 30 mM of NAPS, TAPS, or C 2 -ceramide dramatically increased COX-2 induction (Fig 4B) . In addition, this concentration induced apoptosis e⁄caciously in the HaCaT cells (Fig 3) . Samples were taken at the indicated time points in order to monitor COX-2 production with respect to time after treatment. Production of COX-2 at 30 mM of TAPS became apparent 4 h after treatment, its level reached a maximum at 8 h and decreased thereafter (Fig 4C) . Unlike TAPS, NAPS-induced COX-2 expression increased steadily to a maximum 16 h after treatment and this level was sustained until 24 h. C 2 -ceramide appeared to increase maximally the COX-2 protein level at 8 h, but COX-2 induction by C 2 -ceramide was weak when compared with NAPS or TAPS.
ERK and p38 contribute to the induction of COX-2 by TAPS, but p38 is not involved in the NAPS-induced COX-2 induction It has been reported that the C 2 -ceramideinduced COX-2 promoter activity was inhibited by the dominant negative mutant of ERK 2 and p38 (Chen et al, 2001) . In order to determine if ERK or p38 is also involved in the signaling pathways for the COX-2 induction by the novel PS derivatives NAPS or TAPS in HaCaT cells, the NAPS-or TAPSinduced COX-2 protein level was examined after suppressing either p38 or ERK using their inhibitors. As shown in Fig  5(A,B) , blocking ERK with a selective ERK inhibitor, PD98059 (40 mM), almost completely abrogated the TAPS-induced COX-2 increase at 8 h, whereas it inhibited the NAPS-induced COX-2 increase to a lesser degree. The induction of the COX-2 protein by TAPS was also signi¢cantly inhibited by pretreatment with the p38 inhibitor, SB203580 (5 mM), but no alteration was observed in the COX-2 production induced by NAPS despite the treatment with SB203580, rather it increased slightly. Furthermore, 10 mM U0126, a MEK inhibitor, e¡ectively inhibited the TAPS-induced COX-2 protein, but only inhibited the NAPS-induced COX-2 protein level to a lesser degree, the extent of which was comparable with that inhibited by PD98059, an ERK inhibitor. These results suggest that TAPS increases COX-2 expression via the ERK and p38 pathway. ERK, however, is a greater contributor than p38, and NAPS may not act via p38 pathway.
NAPS and TAPS also increase the COX-2 expression through PI3-kinase It has been reported that ceramide stimulates ¢broblast division by activating tyrosine phosphorylation, Ras, and PI3 -kinase) (Hanna et al, 1999) . Therefore, this study examined whether or not the inhibition of PI3-kinase with LY294002 blocks the COX-2 induction by both NAPS and TAPS. Immunoblot analysis showed that a pretreatment with 20 mM LY294002 for 1 h almost completely prevented the increase in COX-2 protein levels by NAPS or TAPS. These results show that both NAPS and TAPS increase COX-2 expression through PI3 -kinase (Fig 6A,B) .
Tyrosine kinase, src, and PKC are di¡erentially involved in the induction of COX-2 by NAPS or TAPS Figure 6 shows that PI3 -kinase is involved in the NAPS-or TAPSmediated COX-2 induction. One of the mechanisms by which ceramide regulates gene expression is through activating the PKC signal transduction pathway (Subbaramaiah et al, 1998) . COX-2 is a target of activated PKC (Subbaramaiah et al, 1998) . Tyrosine kinase phosphorylates src and PI3 -kinase, which is followed by activation of phospholipase C or PKC. Therefore, genistein (100 mM), which is a tyrosine kinase inhibitor, was used to examine if tyrosine kinase is involved upstream of PI3 -kinase in NAPS-or TAPS-induced COX-2 induction. Immunoblot analysis showed that the genistein pretreatment reduced the TAPS-induced COX-2 protein levels indicating involvement of a tyrosine kinase (Fig 7B) . We also examined if src is involved in the TAPS-induced COX-2 protein induction. The COX-2 protein induction by TAPS was completely prevented by pretreatment with 10 mM PP1, a src inhibitor ( Fig  7B) . In addition, GF109203X, a PKC inhibitor, inhibited the induction of the COX-2 protein by TAPS (Fig 7B) at 5 mM.
The induction of the COX-2 protein by NAPS, however, was not blocked by pretreatment with genistein, PP1, or GF109203X ( Fig 7A) . These results suggest that NAPS and TAPS di¡erentially regulate COX-2 expression. TAPS might regulate COX-2 expression through autophosphorylation of tyrosine kinase, which is followed by the activation of src and PI3-kinase, and ¢nally by the activation of the PKC and/or ERK pathway. The COX-2 expression by NAPS might be also mediated through the PI3 -kinase and ERK pathway. Upstream signal molecules that regulate the COX-2 expression induced by NAPS, however, needs to be further studied. . ERK and p38 contribute to the expression of COX-2 by TAPS, but p38 is not involved in the NAPS-induced COX-2 expression. Induction of the COX-2 protein by NAPS (A) and TAPS (B). The level of the COX-2 protein was assessed by immunoblot, and the relative COX-2 protein levels were plotted after scanning densitometry. Expression of the COX-2 protein was measured from NAPS-treated cells for 16 h or TAPS-treated cells (30 mM) for 8 h after 1 h pretreatment with ERK inhibitor PD98059 (40 mM), p38 inhibitor SB203580 (5 mM), and MEK inhibitor U0126 (10 mM). Data represent the mean7SEM of three separate experiments. One-way analysis of variance was used for the comparisons of the multiple group means followed by Newman^Keuls test (signi¢cance compared with the control, ÃÃ po0.01; signi¢cant compared with NAPS or TAPS, wwpo0.01) (control level ¼ 1).
Treatment with various kinase inhibitors indirectly showed that upregulation of COX-2 by TAPS or NAPS occurs through the ERK pathway or PI3^PKC pathway. We further examined whether TAPS indeed facilitates phosphorylation of MEK or p38, moreover, if these inhibitors are blocking their target pathways as predicted. Results showed that phosphorylation of MEK was detected at early time (E5 min) point after TAPS treatment and sustained until 12 h (Fig 8) . Phospho-p38 was also increased in TAPS-treated cells. TAPS-induced phosphorylation of MEK or p38, however, was inhibited by the preincubation of cells with PD98059 or SB203580. These results suggest that the ERK pathway is mainly involved in COX-2 induction by TAPS. Regarding the signaling pathway related to the COX-2 induction of C 2 -ceramide compared with that of NAPS or TAPS appeared to adopt a signal pathway similar to that of TAPS (Fig 9) .
Inhibition of COX-2 function enhances signi¢cantly NAPSor TAPS-mediated apoptosis NAPS-and TAPS-induced apoptosis was previously shown by TUNEL assay. The e¡ects of the COX-2 inhibition by a selective COX-2 inhibitor, celecoxib, on NAPS-or TAPS-induced apoptosis were examined in order to test if induction of COX-2 is part of a protective mechanism to compensate for NAPS-or TAPS-induced apoptosis. We used 30 mM of NAPS or TAPS, at which concentration COX-2 protein production as well as the sub-G 1 population was remarkably elevated. Twenty-four hours after HaCaT cells were exposed to either NAPS or TAPS with or without celecoxib (10 mM) cells were collected and treated with propidium iodide for the FACScan to determine the sub-G 1 DNA content. FACS analysis showed that the cells exposed to either NAPS or TAPS and celecoxib resulted in a remarkable increase in the cell death rate (Fig 10B) . Co-treatment with NAPS or TAPS and celecoxib increased the sub-G 1 percentage from 26.1 to 56.57% or from 33.4 to 60.47% when compared with the treatment with NAPS or TAPS alone. These results demonstrate that COX-2 protects the cells from NAPS-or TAPS-induced apoptosis, and that an impairment of COX-2 function leads to a pronounced increase in apoptosis.
The sub-G 1 population was monitored by FACS analysis after adding 40 mM PD98059 to the cells treated with NAPS or TAPS (Fig 10B) in order to address whether or not the ERK signaling pathway involved in the COX-2 expression by NAPS or TAPS plays an important part in protecting cells from NAPS-or TAPS-induced apoptosis. It should noted that the cells cotreated with PD98059 increased the sub-G 1 population by up to 44.60% and 53.05%, when it was combined with both NAPS or TAPS. In contrast, p38 inhibition using SB203580 failed to increase the sub-G 1 population by TAPS, and even blocked the sub-G 1 population induced by NAPS from 26.1 to 20.19%. This result corresponds to the fact that p38 inhibition slightly increased the COX-2 expression level induced by NAPS. These results show that the ERK signaling pathway protects cells from the The cell lysate was extracted from the cells treated with TAPS at indicative times and then immunoblot analysis was performed using anti-p-MEK1/2, anti-p-p38, anti-MEK1/2, and anti-p38 antibodies. To determine the speci¢city of the MAPK inhibitors, HaCaT cells were harvested from the cells treated with TAPS for 8 h after preincubation for 1 h with ERK inhibitor PD98059 and p38 inhibitor SB203580. Each lane was loaded with 80 mg of the cell lysates. The data were con¢rmed by three times repeated experiments. apoptosis caused by NAPS or TAPS by being involved in the COX-2 expression. Furthermore, these results provide a notion that p38 might negatively regulate the COX-2 expression by NAPS.
DISCUSSION
This study showed that the PS derivatives, NAPS and TAPS, induced apoptosis more e¡ectively than C 2 -ceramide. It was found through expression array analysis that COX-2 was the most strongly induced gene among the genes upregulated by TAPS at the mRNA level.
It has been reported that a variety of stimuli, including tumor necrosis factor-a, interleukin-1b, phorbol esters, g-interferon, and ultraviolet light stimulate the hydrolysis of sphingomyelin by sphingomyelinase (Smase), which results in the formation of ceramide, and induces COX-2 (Okazaki et al, 1990; Herschman, 1996; Huang et al, 1997; Sbrissa et al, 1997; Buckman et al, 1998) . Therefore, it is possible that these agonists induce COX-2 at least in part, via ceramide signaling. It is known that ceramide induces apoptosis, whereas COX-2 overexpression inhibits apoptosis (Tsujii and DuBois, 1995; Verheij et al, 1996) . Subbaramaiah et al (1998) proposed that the proapoptotic e¡ects of ceramide may be counteracted, in part, by its ability to upregulate COX-2. A detailed mechanism demonstrating the relation between the induction of apoptosis and COX-2 expression by ceramide, however, has not been studied. The mechanism by which novel PS derivatives, NAPS and TAPS, induce COX-2 expression, and its role in the NAPS-or TAPS-mediated apoptosis in human keratinocytes are unclear. Therefore, this study examined the induction mechanism of the COX-2 gene by NAPS and TAPS, and the role of COX-2 in inducing apoptosis.
Ceramide signaling can be mediated by PKC (Sbrissa et al, 1997) . PKC can activate Raf-1, which in turn, regulates the MAPK activity (Reunanen et al, 1998) . Ceramide was previously Figure 9 . C 2 -ceramide induces COX-2 protein through tyrosine kinase, PI3-kinase, and ERK pathway. The cells were treated with 30 mM C 2 -ceramide after preincubation for 1 h with the PI3-kinase inhibitor, LY294002, the ERK inhibitor, PD98059, the p38 inhibitor, SB203580, the MEK inhibitor, U0126, the tyrosine inhibitor, genistein (GT), the src inhibitor, PP1 and the PKC inhibitor, GF109203X. Eight hours later, the cell lysate was extracted from the cells and immunoblot analysis was performed as described in shown to induce the p38, c-Jun N-terminal kinase, and ERK/ MAPK activities (Reunanen et al, 1998) . COX-2 expression can be a¡ected by changes in the MAPK activity Herschman, 1995, 1996; Guan et al, 1998) . Several lines of evidence suggest that the COX-2 induction by ceramide occurs via ERK, c-Jun N-terminal kinase, and p38 MAPK activation Herschman, 1995, 1996; Guan et al, 1998; Subbaramaiah et al, 1998) . This study showed that the induction of COX-2 byTAPS was blocked by GF109203X, a potent and selective PKC inhibitor. In addition, it was found that MEK, ERK, and p38 are important for mediating the induction of COX-2 byTAPS. Moreover, PI3 -kinase was also involved in the COX-2 induction by either NAPS or TAPS; however, we cannot rule out the possibility that the hydrocarbon chains of PS may facilitate a hydrophobic interaction with their cellular targets such as fatty acids, thereby indirectly exerting these e¡ects.
To elucidate further the mechanism by which TAPS signaling induces COX-2 expression, tyrosine kinase and src were also examined to determine if they are involved in COX-2 expression. The results showed that TAPS increased the COX-2 protein level by activating tyrosine kinase and src. This is consistent with previous reports showing that ceramide formation in ¢broblasts stimulates the tyrosine kinase activity (Hanna et al, 1999) , such as pp60 c^src (Su et al, 1999) , resulting in Ras-GTP formation (Hanna et al, 1999) . Treating Rat2 ¢broblasts with ceramide caused PI3 -kinase to interact physically with Ras-GTP (Hanna et al, 1999) and the phosphorylated FAK (Hanna et al, 2001) , resulting in the synergistic activation of PI3 -kinase (Rodriguez-Viciana et al, 1996) .
The regulation mechanism of COX-2 induction by NAPS, however, appeared to di¡er from that induced by TAPS. NAPS increased the COX-2 levels through the MEK and ERK pathways, but not through the p38 pathways. In addition, tyrosine kinase, src, and PKC appeared unlikely to be related to the COX-2 expression by NAPS. NAPS is di¡erent from TAPS in having one N-acetyl group, whereas TAPS has a tetraacetyl group. Lee et al (2001) reported that NAPS (also called C 2 -phytoceramide in that study) showed a much stronger cytotoxic e¡ect than C 2 -ceramide, suggesting that the hydroxyl group at C-4 of the sphingoid long-chain base is crucial for its cytotoxicity. In addition, the size of the N-acyl group is also important for the cytotoxicity. Therefore, the di¡erence in physiologic e¡ect of NAPS and TAPS may be due to the substituent of the sphingoid long chain base. We need to investigate further the upstream signaling molecules involved in the COX-2 expression by NAPS.
It is known that COX-2 overexpression appears to play an important part in carcinogenesis (Wol¡ et al, 1998; Zimmermann et al, 1999) . Recent in vivo studies have shown that COX-2 is also expressed in normal human skin as well as in various kinds of tumor cells (Leong et al, 1996; Muller-Decker et al, 1999) . Leong et al (1996) , however, revealed that COX-2 immunostaining increased in the more di¡erentiated suprabasal keratinocytes suggesting that COX-2 expression occurred as part of normal keratinocyte di¡erentiation. It is possible to propose that the COX-2 overexpression by NAPS and TAPS may be to counteract the increase in the apoptosis rather than to be somehow related to development of the keratinocyte malignancy.
This study provides some information on the mechanism by which novel PS derivatives, TAPS and NAPS, induce COX-2 expression, and demonstrate that COX-2 expression is related to counteracting apoptosis by NAPS or TAPS in human keratinocyte HaCaT cells.
